Russell Investments Group, Ltd. Arvinas, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 10,691 shares of ARVN stock, worth $277,752. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,691

Previous 4,848 120.52%

Holding current value

$277,752

Previous $129,000 103.88%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.66 - $32.73 $138,245 - $191,241	5,843 Added 120.52%	10,691 $263,000
Q2 2024 Aug 08, 2024	SELL	$24.46 - $40.4 $4,500 - $7,433	-184 Reduced 3.66%	4,848 $129,000
Q1 2024 May 08, 2024	SELL	$36.38 - $52.31 $192,159 - $276,301	-5,282 Reduced 51.21%	5,032 $207,000
Q4 2023 Feb 05, 2024	SELL	$14.19 - $42.33 $1.04 Million - $3.09 Million	-72,945 Reduced 87.61%	10,314 $424,000
Q3 2023 Nov 13, 2023	BUY	$19.64 - $28.21 $758,771 - $1.09 Million	38,634 Added 86.57%	83,259 $1.64 Million
Q2 2023 Aug 10, 2023	SELL	$21.73 - $31.43 $170,471 - $246,568	-7,845 Reduced 14.95%	44,625 $1.11 Million
Q1 2023 May 09, 2023	BUY	$26.15 - $37.26 $359,693 - $512,511	13,755 Added 35.53%	52,470 $1.43 Million
Q4 2022 Feb 08, 2023	SELL	$32.47 - $57.24 $241,252 - $425,293	-7,430 Reduced 16.1%	38,715 $1.32 Million
Q3 2022 Nov 04, 2022	SELL	$41.87 - $57.99 $863,861 - $1.2 Million	-20,632 Reduced 30.9%	46,145 $2.05 Million
Q2 2022 Jul 29, 2022	BUY	$36.01 - $74.24 $571,262 - $1.18 Million	15,864 Added 31.16%	66,777 $2.81 Million
Q1 2022 May 05, 2022	BUY	$60.27 - $81.57 $433,522 - $586,733	7,193 Added 16.45%	50,913 $3.43 Million
Q4 2021 Jan 21, 2022	BUY	$65.85 - $96.21 $68,154 - $99,577	1,035 Added 2.42%	43,720 $3.59 Million
Q3 2021 Nov 08, 2021	BUY	$73.2 - $107.87 $594,018 - $875,365	8,115 Added 23.47%	42,685 $3.51 Million
Q2 2021 Aug 04, 2021	BUY	$60.45 - $84.26 $1.98 Million - $2.77 Million	32,819 Added 1874.3%	34,570 $2.66 Million
Q1 2021 May 10, 2021	BUY	$58.19 - $91.37 $101,890 - $159,988	1,751 New	1,751 $115,000
Q4 2020 Feb 08, 2021	SELL	$20.19 - $84.93 $35,352 - $148,712	-1,751 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$29.88 - $56.74 $32,180 - $61,108	-1,077 Reduced 38.08%	1,751 $58,000
Q1 2020 May 06, 2020	BUY	$33.0 - $54.5 $93,324 - $154,126	2,828 New	2,828 $113,000
Q2 2019 Aug 09, 2019	SELL	$15.96 - $23.8 $39,612 - $59,071	-2,482 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.55 - $23.79 $33,631 - $59,046	2,482 New	2,482 $37,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Arvinas, Inc. Transaction History